These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 31778244

  • 1. ICD triple counting leading to a lethal inappropriate shock.
    Korantzopoulos P, Manolis G, Manolis AG.
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):231-233. PubMed ID: 31778244
    [No Abstract] [Full Text] [Related]

  • 2. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N, Boveda S, Defaye P, Klug D, Treguer F, Amet D, Perier MC, Gras D, Algalarrondo V, Bouzeman A, Piot O, Deharo JC, Fauchier L, Babuty D, Bordachar P, Sadoul N, Marijon E, Leclercq C, DAI-PP Investigators.
    Europace; 2018 Jan 01; 20(1):65-72. PubMed ID: 28082419
    [Abstract] [Full Text] [Related]

  • 3. Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter-Defibrillator Failure and Currently Available Options.
    Elayi CS, Charnigo RJ, Heron PM, Lee BK, Olgin JE.
    Circ Arrhythm Electrophysiol; 2017 Jun 01; 10(6):. PubMed ID: 28630173
    [No Abstract] [Full Text] [Related]

  • 4. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
    El-Chami MF, Levy M, Kelli HM, Casey M, Hoskins MH, Goyal A, Langberg JJ, Patel A, Delurgio D, Lloyd MS, Leon AR, Merchant FM.
    J Cardiovasc Electrophysiol; 2015 Aug 01; 26(8):900-904. PubMed ID: 25952566
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA.
    Europace; 2013 Mar 01; 15(3):347-54. PubMed ID: 23002195
    [Abstract] [Full Text] [Related]

  • 6. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
    Akel T, Lafferty J.
    Cardiovasc Ther; 2017 Jun 01; 35(3):. PubMed ID: 28129469
    [Abstract] [Full Text] [Related]

  • 7. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S, Asad Z, Reynolds D.
    J Cardiovasc Electrophysiol; 2017 Jun 01; 28(6):659-665. PubMed ID: 28316104
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.
    Bozyel S, Aktas M, Mutluer FO, Guler TE, Dervis E, Argan O, Celikyurt U, Agir A, Vural A.
    Acta Cardiol; 2019 Jun 01; 74(3):246-251. PubMed ID: 30058473
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T, Fukamizu S, Hojo R, Komiyama K, Tanabe Y, Tejima T, Soejima K, Nishizaki M, Hiraoka M, Ako J, Momomura S, Sakurada H.
    Europace; 2013 Oct 01; 15(10):1507-15. PubMed ID: 23603305
    [Abstract] [Full Text] [Related]

  • 11. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
    Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM.
    Circ Cardiovasc Imaging; 2017 Aug 01; 10(8):. PubMed ID: 28794139
    [Abstract] [Full Text] [Related]

  • 12. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Bansal N, Szpiro A, Masoudi F, Greenlee RT, Smith DH, Magid DJ, Gurwitz JH, Reynolds K, Tabada GH, Sung SH, Dighe A, Cassidy-Bushrow A, Garcia-Montilla R, Hammill S, Hayes J, Kadish A, Sharma P, Varosy P, Vidaillet H, Go AS.
    Heart; 2017 Apr 01; 103(7):529-537. PubMed ID: 27742796
    [Abstract] [Full Text] [Related]

  • 13. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
    Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G.
    Circ Cardiovasc Qual Outcomes; 2015 Mar 01; 8(2):179-86. PubMed ID: 25669833
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of implantable cardioverter defibrillator in nonischaemic cardiomyopathy: a U-turn?
    Gaita F, Castagno D, Anselmino M.
    J Cardiovasc Med (Hagerstown); 2018 Feb 01; 19 Suppl 1():e63-e67. PubMed ID: 29084020
    [No Abstract] [Full Text] [Related]

  • 16. Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Luni FK, Singh H, Khan AR, Malik SA, Khawaja O, Riaz H, Lee W, Kabour A, Richards M, Aasbo J.
    J Cardiovasc Electrophysiol; 2017 May 01; 28(5):538-543. PubMed ID: 28370885
    [Abstract] [Full Text] [Related]

  • 17. Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice.
    Boveda S, Narayanan K, Jacob S, Providencia R, Algalarrondo V, Bouzeman A, Beganton F, Defaye P, Perier MC, Sadoul N, Piot O, Klug D, Gras D, Fauchier L, Bordachar P, Babuty D, Deharo JC, Leclercq C, Marijon E, DAI-PP Investigators.
    J Cardiovasc Electrophysiol; 2017 Jun 01; 28(6):666-673. PubMed ID: 28251724
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB, Solimene F, Pisanò EC, Zanotto G, Calvi V, Pignalberi C, Maglia G, Iacopino S, Quartieri F, Biffi M, Caravati F, Curnis A, Capucci A, Senatore G, Santamaria M, Della Bella P, Manzo M, Giacopelli D, Gargaro A, D'Onofrio A.
    J Cardiovasc Electrophysiol; 2019 Sep 01; 30(9):1626-1635. PubMed ID: 31165517
    [Abstract] [Full Text] [Related]

  • 19. Clinical Outcomes of Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: Lessons from the Israeli ICD Registry.
    Konstantino Y, Haim M, Boxer J, Goldenberg I, Feldman A, Michowitz Y, Glikson M, Suleiman M, Israeli Working Group on Pacing and Electrophysiology.
    J Cardiovasc Electrophysiol; 2016 Jun 01; 27(6):718-23. PubMed ID: 26852908
    [Abstract] [Full Text] [Related]

  • 20. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F, Porta-Sánchez A, Ha ACT, Fischer HD, Wang X, Austin PC, Lee DS, Nanthakumar K.
    J Am Heart Assoc; 2017 Aug 19; 6(8):. PubMed ID: 28862957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.